Results 51 to 60 of about 46,455 (160)

IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia

Pharmacological Research
Cobenfy, a co-formulation of xanomeline and trospium, is the first drug not acting on the dopaminergic system of the CNS approved for the treatment of schizophrenia by the FDA.
Brian Dean
doaj   +1 more source

mPFC Synaptosome Proteomics Reveals Novel Pathways and Muscarinic Receptor Changes in a Learned Helplessness Mouse Model. [PDF]

eNeuro
Abdulla ZI, Garcia-Milian R, Giahyue E, Fertuzinhos S, Collin F, Wang W, Lam TT, Nairn AC, Picciotto MR.   +8 more
europepmc   +1 more source

Efficacy and safety of the muscarinic receptor agonist KarXT (Xanomeline-Trospium) in schizophrenia: a systematic review, meta-analysis and Bayesian sensitivity analysis. [PDF]

Int J Neuropsychopharmacol
Sharma N, Khatib MN, R R, Kaur M, Srivastava M, Barwal A, Prasad GVS, Rajput P, Mittal V, Shabil M, Kumar A, Bushi G, Mehta R, Satapathy P, Sah S.   +14 more
europepmc   +1 more source

Activating Muscarinic Receptor Signaling in Intrapancreatic Neurons Is Required for Parasympathetic Cholinergic Control of Pancreatic Cell Function. [PDF]

Diabetes
Levi NJ, Tamayo Garcia A, Sokolov M, Barro-Soria R, Caicedo A.   +4 more
europepmc   +1 more source

Maternal consumption of a high-fat diet modulates the inflammatory response in their offspring, mediated by the M1 muscarinic receptor. [PDF]

Front Immunol, 2023
Costa SO, Chaves WF, Lopes PKF, Silva IM, Burguer B, Ignácio-Souza LM, Torsoni AS, Milanski M, Rodrigues HG, Desai M, Ross MG, Torsoni MA.   +11 more
europepmc   +1 more source

Dualsteric Agonist for M2 Muscarinic Receptor Causes Oxidative Stress and Mitochondrial Alteration in Human Glioblastoma Cancer Stem Cells. [PDF]

J Neurochem
Guerriero C, De Nuccio C, Petrone M, Rinaldi T, Cirigliano A, Visentin S, Bernardo A, Conti L, Matera C, De Amici M, Dallanoce C, Tata AM.   +11 more
europepmc   +1 more source

Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics. [PDF]

Elife, 2023
Vuckovic Z, Wang J, Pham V, Mobbs JI, Belousoff MJ, Bhattarai A, Burger WAC, Thompson G, Yeasmin M, Nawaratne V, Leach K, van der Westhuizen ET, Khajehali E, Liang YL, Glukhova A, Wootten D, Lindsley CW, Tobin A, Sexton P, Danev R, Valant C, Miao Y, Christopoulos A, Thal DM.   +23 more
europepmc   +1 more source

Transcriptional and functional profiles of muscarinic receptor-expressing neurons in primate lateral prefrontal and anterior cingulate cortices. [PDF]

Commun Biol
Tsolias A, Mojica CA, Yamani R, Khanna SD, Al Abdullatif S, Snyder BJ, Chang W, Guillamon-Vivancos T, Goodliffe J, Capriglione AL, Zhou Y, Tan Palanca IL, Martinez J, Campbell JD, Luebke JI, Zeldich E, Medalla M.   +16 more
europepmc   +1 more source

Muscarinic receptor agonist-induced βPix binding to β-catenin promotes colon neoplasia. [PDF]

Sci Rep, 2023
Cheng K, Chahdi A, Larabee SM, Tolaymat M, Sundel MH, Drachenberg CB, Zhan M, Hu S, Said AH, Shang AC, Xie G, Alizadeh M, Moura NS, Bafford AC, Williams RT, Hanna NN, Raufman JP.   +16 more
europepmc   +1 more source

Muscarinic receptor M3 activation promotes fibrocytes contraction. [PDF]

Front Pharmacol, 2022
Henrot P, Eyraud E, Maurat E, Point S, Cardouat G, Quignard JF, Esteves P, Trian T, Girodet PO, Marthan R, Zysman M, Berger P, Dupin I.   +12 more
europepmc   +1 more source